Ligation of Anterior Internal Iliac Artery With Conservative Management of

Status Recruiting

Clinical Trial Summary

The patients will be divided into 2 groups: Group (A) - Study group: Cases managed by lower segment resection with ligation of the anterior division of the internal iliac artery Group (B) - Control group: Cases managed by lower segment resection without ligation of the anterior division of the internal iliac artery The following operative details will be recorded: - Estimation of total blood loss - Pre and 24-h post-operative hemoglobin (g/dl). - The need for blood transfusion and its amount intra or postoperative will be recorded - Operative time and postoperative hospital stay will be recorded. - Close post-operative monitoring of the patients' vital signs, drain output, and urine output - Presence or absence of intraoperative complications; bladder, ureteric, bowel, or vascular injuries will be recorded. - Monitoring for postoperative morbidities

Clinical Trial Description

The patients will be divided into 2 groups: Group (A) - Study group: Cases managed by uterine lower segment resection with ligation of the anterior division of the internal iliac artery (4 cm distal to the bifurcation of the common iliac artery). Group (B) - Control group: Cases managed by uterine lower segment resection without ligation of the anterior division of the internal iliac artery. In both groups, bilateral uterine artery ligation at 2 levels will be done; bilateral ligation at a level below the lower most placental part, followed by bilateral uterine artery ligation at the level of the hysterotomy incision. The following operative details will be recorded: - Estimation of total blood loss - Pre and 24-h post-operative hemoglobin (g/dl). - The need for blood transfusion and its amount intra or post-operative will be recorded - Operative time and postoperative hospital stay will be recorded. - Close post-operative monitoring of the patients' vital signs, drain output, and urine output - Presence or absence of intraoperative complications; bladder, ureteric, bowel, or vascular injuries will be recorded. - Monitoring for postoperative morbidities ;

Study Design

Related Conditions & MeSH terms

Placenta Accreta

Clinical Trial Details

NCT number	NCT05471102
Study type	Interventional
Source	Cairo University
Contact	amr essam
Phone	01004365349
Email	amro_394@hotmail.com
Status	Recruiting
Phase	N/A
Start date	July 3, 2022
Completion date	November 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04579172` - Conservative Management of Morbidly Adherent Anterior Situated Placenta	N/A
Completed	`NCT04593303` - Internal Iliac Artery Ligation During Management of Placenta Accreta Spectrum	N/A
Recruiting	`NCT03638024` - Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
Not yet recruiting	`NCT06100640` - Paracervical Pouch in Placenta Accreta Spectrum
Completed	`NCT05979181` - Peripartum Cesarean Hysterectomy for Placenta Percreta
Recruiting	`NCT04609527` - Management of Placenta Accreta Spectrum	Phase 2/Phase 3
Recruiting	`NCT06185894` - The Role of Using Tourniquet in Decreasing Bleeding in Placenta Accreta Spectrum Cases	N/A
Completed	`NCT04573452` - Galectin-3 and Placenta Accreta
Not yet recruiting	`NCT03273569` - PDIUC Protocol for Placental Accreta	N/A
Completed	`NCT03707132` - Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
Not yet recruiting	`NCT05104177` - Effectivness of Conservative Techniques in Management of PAS
Completed	`NCT02806024` - Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study	Phase 4
Active, not recruiting	`NCT02784886` - Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta	N/A
Recruiting	`NCT05070689` - Placenta Accreta Spectrum Disorders: A. Chohan Continuous Squeezing Suture (ACCSS)	N/A
Completed	`NCT05813743` - Detection of Urinary Bladder Wall Involvement in Abnormally Invasive Placenta (AIP) by 3D Ultrasonography	N/A
Withdrawn	`NCT04003428` - Feasibility of HIFU for Management of Placenta Accreta (HIFU-ACCRETA)	N/A
Completed	`NCT04161521` - Conservative Surgical Novel Technique of Placenta Accreta in Menoufia University Hospital	N/A
Recruiting	`NCT05139498` - Conservative Management for PAS Pilot	N/A
Not yet recruiting	`NCT03530475` - Diagnostic Accuracy of Doppler Ultrasound and Role of Uterine Artery Doppler	N/A
Recruiting	`NCT05922397` - Placenta Accreta Spectrum Topographic Classification

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Ligation of Anterior Internal Iliac Artery With Conservative Management of Partial or Focal Placenta Accreta Spectrum

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms